pharma · Advanced Solid Tumor · XLO
Xilio Therapeutics
Xilio Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Waltham, USA HQ
2016 Founded
89 Employees
Public company Type
XLO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Founded
- 2016
- Employees
- 89
- Programs
- 3
- Drugs
- 0
- Patents
- 7
Xilio Therapeutics pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Xilio Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.